Sofgen Pharma S.A. Profit Margin

As of the most recent data (December 2023), PROCF shows a profit margin of 9.52%. That compares with 10.38% in the prior-year period — down 8.3% year over year. That is below the Healthcare sector average of 9.71%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PROCF's profit margin is now 9.52% (was 10.38%) — a 8.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Sofgen Pharma S.A. is outperforming or lagging.

The Healthcare sector average profit margin is about 9.71%. Sofgen Pharma S.A. is at 9.52%, which is lower that average. That is roughly 1.9% below the sector mean. Use the comparison chart on this page to see how PROCF stacks up against individual peers as well.

That compares with 10.38% in the prior-year period — down 8.3% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Sofgen Pharma S.A. with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Sofgen Pharma S.A.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 9.52%) with ownership activity and broader fundamentals.